Kaposi sarcoma: A continuing conundrum

Journal of the American Academy of Dermatology

Volumn 59, Issue 2, 2008, Pages 179-206

  Schwartz, Robert A ^a   Micali, Giuseppe ^b   Nasca, Maria Rita ^b   Scuderi, Laura ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHORIONIC GONADOTROPIN; CIDOFOVIR; CIMETIDINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FOSCARNET; IMIQUIMOD; PACLITAXEL; PIOGLITAZONE; RAPAMYCIN; RETINOIC ACID; RETINOID DERIVATIVE; ROFECOXIB; SEMAXANIB; TETRACYCLINE DERIVATIVE; THALIDOMIDE; TROFOSFAMIDE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LEUKEMIA; AFRICA; ANTIANGIOGENIC THERAPY; ANTIVIRAL THERAPY; APPENDICITIS; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHYLOTHORAX; CLAY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DOSAGE SCHEDULE COMPARISON; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ELECTRON MICROSCOPY; ENTEROPATHY; GRAFT RECIPIENT; HERPES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IATROGENIC DISEASE; IMMUNOBLASTIC LYMPHOMA; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INSECT; INTESTINE OBSTRUCTION; INTRAVENOUS DRUG ABUSE; ITALY; KAPOSI SARCOMA; LASER SURGERY; LOW DRUG DOSE; LUNG SMALL CELL CANCER; LYMPHADENOPATHY; LYMPHEDEMA; LYMPHOMA; MALE HOMOSEXUAL; MONOTHERAPY; MOUTH LESION; MULTIPLE CYCLE TREATMENT; NEOPLASM; NEUTROPENIA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; OPTIMAL DRUG DOSE; PANDEMIC; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETICULOENDOTHELIAL NEOPLASM; REVIEW; SECONDARY INFECTION; SEXUAL TRANSMISSION; SKIN DEFECT; SKIN INFECTION; SKIN MANIFESTATION; TESTIS CANCER; TISSUE DISTRIBUTION; TREATMENT RESPONSE; ULTRASTRUCTURE; UNITED KINGDOM; UNITED STATES; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT OBSTRUCTION; VASCULAR LESION; WALKING DIFFICULTY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; GREAT BRITAIN; GREECE; HUMANS; IMMUNOCOMPROMISED HOST; ITALY; PREVALENCE; SARCOMA, KAPOSI; SKIN NEOPLASMS; UNITED STATES;

EID: 47049117356     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.05.001     Document Type: Review

References (363)

1. Schiavo A.L., Ruocco V., Marino F., Ferraiolo S., Pinto F., and Orlando G. Tommaso de Amicis, Augusto Ducrey, Lodovico Tommasi: three Neapolitan stars in the dermatovenereology firmament. Int J Dermatol 35 (1996) 57-62
2. Kaposi M. Pathology and treatment of diseases of the skin for practitioners and students. Johnson JC, trans (1895), William Wood & Co, New York pp. 601-3
3. Schwartz R.A. Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 34 (1996) 804-814
4. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. [in German]. Arch Dermatol Syph (Prague) 4 (1872) 265-273
5. Richter F., Hill G.J., and Schwartz R.A. Professor Kaposi's original concepts of Kaposi's sarcoma. J Cancer Educ 10 (1995) 113-116
6. Gottlieb G.J., Ragaz A., Vogel J.V., Friedman-Kien A., Rywlin A.M., Weiner E.A., et al. A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol 3 (1981) 111-114
7. Friedman-Kien A.E. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 5 (1981) 468-471
8. Centers for Disease Control and Prevention. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep 30 (1981) 305-308
9. Borkovic S.P., and Schwartz R.A. Kaposi's sarcoma presenting in the homosexual man-a new and striking phenomenon!. Ariz Med 38 (1981) 902-904
10. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2 (2002) 281-292
11. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2 (2002) 344-352
12. Dourmishev L.A., Dourmishev A.L., Palmeri D., Schwartz R.A., and Lukac D.M. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67 (2003) 175-212
13. Schwartz R.A., Volpe J.A., Lambert M.W., and Lambert W.C. Kaposi's sarcoma. Semin Dermatol 3 (1984) 303-315
14. Schwartz R.A. Kaposi's sarcoma: an update. J Surg Oncol 87 (2004) 146-151
15. Schwartz RA, Lambert WC. Kaposi sarcoma. eMedicine Dermatology [serial online]. March 13, 2008. Available at: http://emedicine.com/derm/topic203.htm. Accessed May 9, 2008.
16. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 (2005) 635-644
17. Portsmouth S., Stebbing J., Gill J., Mandalia S., Bower M., Nelson M., et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17 (2003) F17-F22
18. Rezza G., Tchangmena O.B., Andreoni M., Bugarini R., Toma L., Bakary D.K., et al. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 27 (2000) 159-164
19. Rezza G., Dorrucci M., Serraino D., Andreoni M., Giuliani M., Zerboni R., et al. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS 14 (2000) 1647-1653
20. Grabar S., Lanoy E., Allavena C., Mary-Krause M., Bentata M., Fischer P., et al. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med 9 (2008) 246-256
21. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
22. Moore P.S., and Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu Rev Microbiol 57 (2003) 609-639
23. Moore P.S., and Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 147 (1998) 217-221
24. Vogel J., Hinrichs S.H., Reynolds R.K., Luciw P.A., and Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335 (1988) 606-611
25. Nair B.C., DeVico A.L., Nakamura S., Copeland T.D., Chen Y., Patel A., et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255 (1992) 1430-1432
26. Miles S.A., Martinez-Maza O., Rezai A., Magpantay L., Kishimoto T., Nakamura S., et al. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255 (1992) 1432-1434
27. Cai J., Gill P.S., Masood R., Chandrasoma P., Jung B., Law R.E., et al. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 145 (1994) 74-79
28. Naidu Y.M., Rosen E.M., Zitnick R., Goldberg I., Park M., Naujokas M., et al. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A 91 (1994) 5281-5285
29. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371 (1994) 674-680
30. Giraldo G., Beth E., and Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst 49 (1972) 1509-1526
31. Giraldo G., Beth E., and Huang E.S. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 26 (1980) 23-29
32. Sanders C.J., Canninga-van Dijk M.R., and Borleffs J.C. Kaposi's sarcoma. Lancet 364 (2004) 1549-1552
33. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., and Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86 (1995) 2708-2714
34. Cesarman E., Nador R.G., Aozasa K., Delsol G., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol 149 (1996) 53-57
35. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93 (1996) 14862-14867
36. Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 70 (1996) 549-558
37. Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., and Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2 (1996) 918-924
38. Gao S.J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2 (1996) 925-928
39. Kirshner J.R., Lukac D.M., Chang J., and Ganem D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 74 (2000) 3586-3597
40. Lagunoff M., Lukac D.M., and Ganem D. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75 (2001) 5891-5898
41. Liang Y., Chang J., Lynch S.J., Lukac D.M., and Ganem D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16 (2002) 1977-1989
42. Carroll K.D., Bu W., Palmeri D., Spadavecchia S., Lynch S.J., Marras S.A., et al. Kaposi's sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol 80 (2006) 9697-9709
43. Palmeri D., Spadavecchia S., Carroll K.D., and Lukac D.M. Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J Virol 81 (2007) 13299-13314
44. Cerimele D., Cottoni F., and Masala M.V. Long latency of human herpesvirus type 8 infection and the appearance of classic Kaposi's sarcoma. J Am Acad Dermatol 43 (2000) 731-732
45. Radkov S.A., Kellam P., and Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6 (2000) 1121-1127
46. Lee B.S., Alvarez X., Ishido S., Lackner A.A., and Jung J.U. Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J Exp Med 192 (2000) 11-21
47. Huang L.M., Chao M.F., Chen M.Y., Shih H., Chiang Y.P., Chuang C.Y., et al. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J Biol Chem 276 (2001) 13427-13432
48. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., and Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345 (1990) 84-86
49. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Sturzl M., and Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 37 (2001) 1251-1269
50. Toschi E., Barillari G., Sgadari C., Bacigalupo I., Cereseto A., Carlei D., et al. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 12 (2001) 2934-2946
51. Sturzl M., Zietz C., Monini P., and Ensoli B. Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. Adv Cancer Res 81 (2001) 125-159
52. Duprez R., Lacoste V., Brière J., Couppié P., Frances C., Sainte-Marie D., et al. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst 99 (2007) 1086-1094
53. Cazorla Jimenez A., Gorgolas Hernandez-Mora M., Fernandez Guerrero M., Renedo Pascual G., and Rivas Manga C. Multicenter Castleman disease in AIDS. Its relationship with HHV-8 or herpes virus associated to Kaposi's sarcoma. Study of two cases. [In Spanish]. Rev Clin Esp 205 (2005) 607-609
54. Engels E.A., Rosenberg P.S., Frisch M., and Goedert J.J. Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma. Br J Cancer 85 (2001) 1298-1303
55. Muralidhar S., Veytsmann G., Chandran B., Ablashi D., Doniger J., and Rosenthal L.J. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol 16 (2000) 203-213
56. Muralidhar S., Pumfery A.M., Hassani M., Sadaie M.R., Kishishita M., Brady J.N., et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 72 (1998) 4980-4988
57. Pantanowitz L., and Dezube B.J. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr Opin Oncol 16 (2004) 443-449
58. Simonart T. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Cancer Lett 244 (2006) 1-7
59. Lu C., Zeng Y., Huang Z., Huang L., Qian C., Tang G., et al. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am J Pathol 166 (2005) 173-183
60. Girard C., Ottomani L., Ducos J., Dereure O., Carles M.J., and Guillot B. High prevalence of torque teno (TT) virus in classical Kaposi's sarcoma. Acta Derm Venereol 87 (2007) 14-17
61. Ruocco V., Schwartz R.A., and Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 47 (2002) 124-127
62. Micali G., Gasparri O., and Nasca M.R. Sarcoma di Kaposi epidemico insorto "de novo" in sede di trauma. Considerazioni etiopatologiche. [in Italian]. Dermatologia Clinica 9 (1991) 151-154
63. Ziegler J.L., Simonart T., and Snoeck R. Kaposi's sarcoma, oncogenic viruses, and iron. J Clin Virol 20 (2001) 127-130
64. Cook P.M., Whitby D., Calabro M.L., Luppi M., Kakoola D.N., Hjalgrim H., et al. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS 13 (1999) 1165-1176
65. Whitby D., Marshall V.A., Bagni R.K., Wang C.D., Gamache C.J., Guzman J.R., et al. Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 85 (2004) 155-163
66. Jenson H.B. Human herpesvirus 8 infection. Curr Opin Pediatr 15 (2003) 85-91
67. Crispo A., Tamburini M., De Marco M.R., Ascierto P., Silvestro P., Ronga D., et al. HHV-8 prevalence, immunosuppression and Kaposi's sarcoma in south Italy. Int J Mol Med 7 (2001) 535-538
68. Cattani P., Capuano M., Cerimele F., La Parola I.L., Santangelo R., Masini C., et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 37 (1999) 1150-1153
69. Taylor M.M., Chohan B., Lavreys L., Hassan W., Huang M.L., Corey L., et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 190 (2004) 484-488
70. Malope B.I., Pfeiffer R.M., Mbisa G., Stein L., Ratshikhopha E.M., O'Connell D.L., et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 44 (2007) 351-355
71. Brayfield B.P., Kankasa C., West J.T., Muyanga J., Bhat G., Klaskala W., et al. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission. J Infect Dis 189 (2004) 2260-2270
72. Coluzzi M., Manno D., Guzzinati S., Tognazzo S., Zambon P., Arca B., et al. The bloodsucking arthropod bite as possible cofactor in the transmission of human herpesvirus-8 infection and in the expression of Kaposi's sarcoma disease. Parassitologia 44 (2002) 123-129
73. Coluzzi M., Calabro M.L., Manno D., Chieco-Bianchi L., Schulz T.F., and Ascoli V. Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol 17 (2003) 461-464
74. Ascoli V., Facchinelli L., Valerio L., Zucchetto A., Dal Maso L., and Coluzzi M. Distribution of mosquito species in areas with high and low incidence of classic Kaposi's sarcoma and seroprevalence for HHV-8. Med Vet Entomol 20 (2006) 198-208
75. Angeloni A., Heston L., Uccini S., Sirianni M.C., Cottoni F., Masala M.V., et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 177 (1998) 1715-1718
76. Angeloni A., Masala M.V., Montesu M.A., Santarelli R., Satta R., Ceccherini-Nelli L., et al. Environmental factors influence the rate of human herpesvirus type 8 infection in a population with high incidence of classic Kaposi sarcoma. Clin Infect Dis 42 (2006) e66-e68
77. Cottoni F., Masala M.V., Budroni M., Rosella M., Satta R., Locatelli F., et al. The role of occupation and a past history of malaria in the etiology of classic Kaposi's sarcoma: a case-control study in north-east Sardinia. Br J Cancer 76 (1997) 1518-1520
78. Santarelli R., De Marco R., Masala M.V., Angeloni A., Uccini S., Pacchiarotti R., et al. Direct correlation between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in northern Sardinia. J Med Virol 65 (2001) 368-372
79. Cottoni F., Masala M.V., Pattaro C., Pirodda C., Montesu M.A., Satta R., et al. Classic Kaposi sarcoma in northern Sardinia: a prospective epidemiologic overview (1977-2003) correlated with malaria prevalence (1934). J Am Acad Dermatol 55 (2006) 990-995
80. Serraino D., Cerimele D., Piselli P., Aztori L., Farchi F., Carletti F., et al. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia. Infection 34 (2006) 39-42
81. Gill P.S. The origin of Kaposi sarcoma. J Natl Cancer Inst 18 (2007) 99:1063
82. Chen N., Nelson K.E., Jenkins F.J., Suriyanon V., Duerr A., Costello C., et al. Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis 39 (2004) 1052-1058
83. Serwin A.B., Mysliwiec H., Wilder N., Schwartz R.A., and Chodynicka B. Three cases of classic Kaposi's sarcoma with different subtypes of Kaposi's sarcoma-associated herpesvirus. Int J Dermatol 45 (2006) 843-846
84. Foreman K.E., Alkan S., Krueger A.E., Panella J.R., Swinnen L.J., and Nickoloff B.J. Geographically distinct HHV-8 DNA sequences in Saudi Arabian iatrogenic Kaposi's sarcoma lesions. Am J Pathol 153 (1998) 1001-1004
85. Cassar O., Afonso P.V., Bassot S., Plancoulaine S., Duprez R., Capuano C., et al. Novel human herpesvirus 8 subtype D strains in Vanuatu, Melanesia. Emerg Infect Dis 13 (2007) 1745-1748
86. Davidovici B., Karakis I., Bourboulia D., Ariad S., Zong J., Benharroch D., et al. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 93 (2001) 194-202
87. Zhang Y.J., Davis T.L., Wang X.P., Deng J.H., Baillargeon J., Yeh I.T., et al. Distinct distribution of rare US genotypes of Kaposi's sarcoma-associated herpesvirus (KSHV) in South Texas: implications for KSHV epidemiology. J Infect Dis 183 (2001) 125-129
88. Biggar R.J., Whitby D., Marshall V., Linhares A.C., and Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 181 (2000) 1562-1568
89. Renwick N., Dukers N.H., Weverling G.J., Sheldon J.A., Schulz T.F., Prins M., et al. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 185 (2002) 1808-1812
90. Serraino D., Corona R.M., Giuliani M., Farchi F., Sarmati L., Uccella I., et al. Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria. Infection 31 (2003) 47-50
91. Hjalgrim H., Tulinius H., Dalberg J., Hardarson S., Frisch M., and Melbye M. High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. Br J Cancer 77 (1998) 1190-1193
92. Montesu M., Rossella M., and Cottoni F. Le sedi nel sarcoma di Kaposi classico. Studio su una casistica di 200 pazienti. [in Italian]. G Ital Dermatol Venereol 133 (1998) 247-250
93. Montesu M.A., De Marco R., and Cottoni F. Soil silicates and Kaposi's sarcoma in Sardinia. Lancet 346 (1995) 1436-1437
94. Cottoni F., De Marco R., and Montesu M.A. Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br J Cancer 73 (1996) 1132-1133
95. Laor Y., and Schwartz R.A. Epidemiologic aspects of American Kaposi's sarcoma. J Surg Oncol 12 (1979) 299-303
96. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., and Mugerwa J.W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 54 (1993) 26-36
97. Ziegler J.L., and Katongole-Mbidde E. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 65 (1996) 200-203
98. Ziegler J.L., Templeton A.C., and Vogel C.L. Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Semin Oncol 11 (1984) 47-52
99. Diociaiuti A., Nanni G., Cattani P., Lesnoni La Parola I., Masini C., Capuano M., et al. HHV8 in renal transplant recipients. Transpl Int 13 Suppl 1 (2000) S410-S412
100. Iscovich J., Boffetta P., Franceschi S., Azizi E., and Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 88 (2000) 500-517
101. Grulich A.E., Beral V., and Swerdlow A.J. Kaposi's sarcoma in England and Wales before the AIDS epidemic. Br J Cancer 66 (1992) 1135-1137
102. Hiatt K.M., Nelson A.M., Lichy J.H., and Fanburg-Smith J.C. Classic Kaposi sarcoma in the United States over the last two decades: A clinicopathologic and molecular study of 438 non-HIV-related Kaposi sarcoma patients with comparison to HIV-related Kaposi sarcoma. Mod Pathol 21 (2008) 572-582
103. Dictor M., and Attewell R. Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int J Cancer 42 (1988) 346-351
104. Morand J.J., Lightburn E., Simon F., and Patte J.H. Update on Kaposi's sarcoma. [in French]. Med Trop (Mars) 67 (2007) 123-130
105. Guttman-Yassky E., Bar-Chana M., Yukelson A., Linn S., Friedman-Birnbaum R., Bergman R., et al. Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer 89 (2003) 1657-1660
106. Engels E.A., Clark E., Aledort L.M., Goedert J.J., and Whitby D. Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City. Int J Epidemiol 31 (2002) 946-950
107. Dal Maso L., Polesel J., Ascoli V., Zambon P., Budroni M., Ferretti S., et al. Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer 92 (2005) 188-193
108. Vitale F., Briffa D.V., Whitby D., Maida I., Grochowska A., Levin A., et al. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 91 (2001) 588-591
109. Geddes M., Franceschi S., Barchielli A., Falcini F., Carli S., Cocconi G., et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69 (1994) 333-336
110. Atzori L., Fadda D., Ferreli C., Pastorelli C., Iannelli P., Rais M., et al. Classic Kaposi's sarcoma in southern Sardinia, Italy. Br J Cancer 91 (2004) 1261-1262
111. Ascoli V., Zambon P., Manno D., Guzzinati S., Zorzi M., Arca B., et al. Variability in the incidence of classic Kaposi's sarcoma in the Veneto region, northern Italy. [in Italian]. Tumori 89 (2003) 122-124
112. Stratigos J.D., Katoulis A.C., and Stavrianeas N.G. An overview of classic Kaposi's sarcoma in Greece. Adv Exp Med Biol 455 (1999) 503-506
113. Stratigos J.D., Potouridou I., Katoulis A.C., Hatziolou E., Christofidou E., Stratigos A., et al. Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile. Int J Dermatol 36 (1997) 735-740
114. Alzahrani A.J., El-Harith e.-H.A., Milzer J., Obeid O.E., Stuhrmann M., Al-Dayel A., et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 20 (2005) 2532-2536
115. Valdarchi C., Serraino D., Cordiali Fei P., Castilletti C., Trento E., Farchi F., et al. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy. Infection 35 (2007) 22-25
116. Mohanna S., Ferrufino J.C., Sanchez J., Bravo F., and Gotuzzo E. Epidemiological and clinical characteristics of classic Kaposi's sarcoma in Peru. J Am Acad Dermatol 53 (2005) 435-441
117. Goedert J.J. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27 (2000) 390-401
118. Borkovic S.P., and Schwartz R.A. Kaposi's sarcoma. Am Fam Physician 26 4 (1982) 133-137
119. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., and Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338 (1998) 948-954
120. Dore G.J., Li Y., Grulich A.E., Hoy J.F., Mallal S.A., Mijch A.M., et al. Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort. AIDS 10 (1996) 1401-1406
121. Melbye M., Cook P.M., Hjalgrim H., Begtrup K., Simpson G.R., Biggar R.J., et al. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 77 (1998) 543-548
122. Renwick N., Halaby T., Weverling G.J., Dukers N.H., Simpson G.R., Coutinho R.A., et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 12 (1998) 2481-2488
123. Osmond D.H., Buchbinder S., Cheng A., Graves A., Vittinghoff E., Cossen C.K., et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 287 (2002) 221-225
124. Mocroft A., Kirk O., Clumeck N., Gargalianos-Kakolyris P., Trocha H., Chentsova N., et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer 100 (2004) 2644-2654
125. Gallafent J.H., Buskin S.E., De Turk P.B., and Aboulafia D.M. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 23 (2005) 1253-1260
126. Clifford G.M., Polesel J., Rickenbach M., Dal Maso L., Keiser O., Kofler A., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 (2005) 25-432
127. Yoshioka M.C., Alchorne M.M., Porro A.M., and Tomimori-Yamashita J. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil. Int J Dermatol 43 (2004) 643-647
128. Athale U.H., Patil P.S., Chintu C., and Elem B. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol 8 (1995) 96-100
129. Atkinson J.O., Biggar R.J., Goedert J.J., and Engels E.A. The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States. J Acquir Immune Defic Syndr 37 (2004) 1282-1287
130. Zavos G., Bokos J., Papaconstantinou I., Boletis J., Gazouli M., Kakisis J., et al. Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 28 (2004) 595-599
131. Farge D. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 2 (1993) 339-343
132. Penn I. Cancers following cyclosporine therapy. Transplant Proc 19 (1987) 2211-2213
133. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 27 (1979) 8-11
134. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 64 (1997) 669-673
135. Qunibi W., Al-Furayh O., Almeshari K., Lin S.F., Sun R., Heston L., et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 65 (1998) 583-585
136. Duman S., Toz H., Asci G., Alper S., Ozkahya M., Unal I., et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant 17 (2002) 892-896
137. Stribling J., Weitzner S., and Smith G.V. Kaposi's sarcoma in renal allograft recipients. Cancer 42 (1978) 442-446
138. Tessari G., Naldi L., Boschiero L., Cordiano C., Piaserico S., Fortina A.B., et al. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 16 (2006) 553-557
139. Cattani P., Capuano M., Graffeo R., Ricci R., Cerimele F., Cerimele D., et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 39 (2001) 506-508
140. Lesnoni La Parola I., Masini C., Nanni G., Diociaiuti A., Panocchia N., and Cerimele D. Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996. Dermatology 194 (1997) 229-233
141. Sabeel A.I., Qunibi W.Y., Alfurayh O.A., and Al-Meshari K. Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single center. J Nephrol 16 (2003) 412-416
142. Hoshaw R.A., and Schwartz R.A. Kaposi's sarcoma after immunosuppressive therapy with prednisone. Arch Dermatol 116 (1980) 1280-1282
143. Hudnall S.D., Rady P.L., Tyring S.K., and Fish J.C. Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation 67 (1999) 648-652
144. Parravicini C., Olsen S.J., Capra M., Poli F., Sirchia G., Gao S.J., et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 90 (1997) 2826-2829
145. Marcelin A.G., Roque-Afonso A.M., Hurtova M., Dupin N., Tulliez M., Sebagh M., et al. Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl 10 (2004) 295-300
146. Nagy S., Gyulai R., Kemeny L., Szenohradszky P., and Dobozy A. Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy. Transplantation 69 (2000) 2230-2231
147. Sarid R., Pizov G., Rubinger D., Backenroth R., Friedlaender M.M., Schwartz F., et al. Detection of human herpesvirus-8 DNA in kidney allografts prior to the development of Kaposi's sarcoma. Clin Infect Dis 32 (2001) 1502-1505
148. Frances C., Mouquet C., Marcelin A.G., Barete S., Agher R., Charron D., et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation 69 (2000) 1776-1779
149. Schwartz R.A. Kaposi's sarcoma. Ann Transplant 3 (1998) 5-12
150. Khan M.Y., Khanam H., Koneru B., and Schwartz R.A. Kaposi's sarcoma in a liver transplant series. J Med 30 (1999) 185-190
151. Micali G., Gasparri O., Nasca M.R., and Sapuppo A. Kaposi's sarcoma occurring de novo in the surgical scar in a heart transplant recipient. J Am Acad Dermatol 27 (1992) 273-274
152. Agbaht K., Pepedil F., Kirkpantur A., Yilmaz R., Arici M., and Turgan C. A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature. Ren Fail 29 (2007) 107-110
153. Mezalek Z.T., Harmouche H., Attar N.E., Serraj K., Aouni M., Adnaoui M., et al. Kaposi's sarcoma in association with Behçet's disease: case report and literature review. Semin Arthritis Rheum 36 (2007) 328-331
154. Antón E. Kaposi's sarcoma in an immunocompetent patient following corticosteroid therapy. Eur J Intern Med 19 (2008) 226
155. Lothe F. Kaposi's sarcoma in Uganda Africans. Acta Pathol Microbiol Scand Suppl Suppl 161 (1963) 1+
156. Thijs A. Kaposi's angiosarcomatosis in the Belgian Congo & Ruanda-Urundi. [in French]. Ann Soc Belg Med Trop 1957 37 (1920) 295-308
157. Serwadda D., Carswell W., Ayuko W.O., Wamukota W., Madda P., and Downing R.G. Further experience with Kaposi's sarcoma in Uganda. Br J Cancer 53 (1986) 497-500
158. Phillips J.I., and Sher R. Kaposi's sarcoma in different populations in South Africa. S Afr Med J 71 (1987) 615-619
159. Nnoruka E.N. Epidemic (human immunodeficiency virus-related) Kaposi's sarcoma in West African women. Int J Dermatol 42 (2003) 794-799
160. Stein M.E., Spencer D., Ruff P., Lakier R., MacPhail P., and Bezwoda W.R. Endemic African Kaposi's sarcoma: clinical and therapeutic implications. 10-year experience in the Johannesburg Hospital (1980-1990). Oncology 51 (1994) 63-69
161. Templeton A.C., and Bhana D. Prognosis in Kaposi's sarcoma. J Natl Cancer Inst 55 (1975) 1301-1304
162. Templeton A.C. Kaposi's sarcoma. Pathol Annu 16 (1981) 315-336
163. Ziegler J., Newton R., Bourboulia D., Casabonne D., Beral V., Mbidde E., et al. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer 103 (2003) 233-240
164. Meditz A.L., Borok M., MaWhinney S., Gudza I., Ndemera B., Gwanzura L., and Campbell T.B. Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe. J Acquir Immune Defic Syndr 44 (2007) 306-308
165. Onunu A.N., Okoduwa C., Eze E.U., Adeyekun A.A., Kubeyinje E.P., and Schwartz R.A. Kaposi's sarcoma in Nigeria. Int J Dermatol 46 (2007) 264-267
166. Volberding P.A. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am 70 (1986) 665-675
167. Schwartz R.A. Skin cancer: recognition and management. 2nd ed. (2008), Blackwell, Oxford, United Kingdom: pp. 79-94
168. Buchbinder A., and Friedman-Kien A.E. Clinical aspects of Kaposi's sarcoma. Curr Opin Oncol 4 (1992) 867-874
169. Sapienza G., Nasca M.R., Dinotta F., and Micali G. Guess what. Classic Kaposi's sarcoma. Eur J Dermatol 11 (2001) 157-158
170. Levine A.M., and Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 37 (2001) 1288-1295
171. Celleno L., Mastroianni A., Borgia M.G., and Cerimele D. Sarcoma di Kaposi. [in Italian]. G Ital Dermatol Venereol 134 (1999) 135-137
172. Frans E., Blockmans D., Peetermans W., Knockaert D., and Bobbaers H. Kaposi's sarcoma presenting as generalized lymphedema. Acta Clin Belg 49 (1994) 19-22
173. Bossuyt L., Van den Oord J.J., and Degreef H. Lymphangioma-like variant of AIDS-associated Kaposi's sarcoma with pronounced edema formation. Dermatology 190 (1995) 324-326
174. Schwartz R.A., Burgess G.H., and Hoshaw R.A. Patch stage Kaposi's sarcoma. J Am Acad Dermatol 2 (1980) 509-512
175. Schwartz R.A., Kardashian J.F., McNutt N.S., Crain W.R., Welch K.L., and Choy S.H. Cutaneous angiosarcoma resembling anaplastic Kaposi's sarcoma in a homosexual man. Cancer 51 (1983) 721-726
176. Schwartz R.A., Brenden L.D., Breeden J.H., and Lambert W.C. Indolent lymphadenopathic Kaposi's sarcoma. J Surg Oncol 34 (1987) 243-247
177. Snyder R.A., and Schwartz R.A. Telangiectatic Kaposi's sarcoma. Occurrence in a patient with thymoma and myasthenia gravis receiving long-term immunosuppressive therapy. Arch Dermatol 118 (1982) 1020-1021
178. Schwartz R.A., Spicer M.S., Thomas I., Janniger C.K., and Lambert W.C. Ecchymotic Kaposi's sarcoma. Cutis 56 (1995) 104-106
179. Schwartz R.A., Spicer M.S., Janniger C.K., Cohen P.J., Melczer M.M., and Lambert W.C. Keloidal Kaposi's sarcoma: report of three patients. Dermatology 189 (1994) 271-274
180. Davis D.A., and Scott D.M. Lymphangioma-like Kaposi's sarcoma: etiology and literature review. J Am Acad Dermatol 43 (2000) 123-127
181. Folpe A.L., Veikkola T., Valtola R., and Weiss S.W. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 13 (2000) 180-185
182. Ramirez J.A., Laskin W.B., and Guitart J. Lymphangioma-like Kaposi sarcoma. J Cutan Pathol 32 (2005) 286-292
183. Katona I., Torok L., and Sérenyi P. Cystic Kaposi's sarcoma. Acta Dermatovenerol Alp Panonica Adriat 4 (1995) 63-66
184. De Pasquale R., Nasca M.R., and Micali G. Postirradiation primary Kaposi's sarcoma of the head and neck. J Am Acad Dermatol 40 (1999) 312-314
185. Maral T. The Koebner phenomenon in immunosuppression-related Kaposi's sarcoma. Ann Plast Surg 44 (2000) 646-648
186. Wolf R., Brenner S., Ruocco V., and Filioli F.G. Isotopic response. Int J Dermatol 34 (1995) 341-348
187. Kua H.W., Merchant W., and Waugh M.A. Oral Kaposi's sarcoma in a non-HIV homosexual white male. Int J STD AIDS 15 (2004) 775-777
188. Feller L., Lemmer J., Wood N.H., and Raubenheimer E.J. Necrotizing gingivitis of Kaposi sarcoma affected gingivae. SADJ 61 (2006) 314-317
189. Micali G., Nasca M.R., De Pasquale R., and Innocenzi D. Primary classic Kaposi's sarcoma of the penis: report of a case and review. J Eur Acad Dermatol Venereol 17 (2003) 320-323
190. Gonen M., Cenker A., Kiyici H., and Kalkan M. Penile Kaposi's sarcomas in a circumcised and HIV-seronegative patient. Int J Urol 13 (2006) 318-320
191. Schwartz R.A., Cohen J.B., Watson R.A., Gascon P., Ahkami R.N., Ruszczak Z., et al. Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol 142 (2000) 153-156
192. Cox F.H., and Helwig E.B. Kaposi's sarcoma. Cancer 12 (1959) 289-298
193. Cottoni F., Masala M.V., Piras P., Montesu M.A., and Cerimele D. Mucosal involvement in classic Kaposi's sarcoma. Br J Dermatol 148 (2003) 1273-1274
194. Ruszczak Z., Stadler R., and Schwartz R.A. Kaposi's sarcoma limited to penis treated with cobalt-60 radiotherapy. J Med 27 (1996) 211-220
195. Lozada F., Silverman Jr. S., Migliorati C.A., Conant M.A., and Volberding P.A. Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 56 (1983) 491-494
196. Lemlich G., Schwam L., and Lebwohl M. Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases. J Am Acad Dermatol 16 (1987) 319-325
197. Kolios G., Kaloterakis A., Filiotou A., Nakos A., and Hadziyannis S. Gastroscopic findings in Mediterranean Kaposi's sarcoma (non-AIDS). Gastrointest Endosc 42 (1995) 336-339
198. Rosella M., Masotti A., and Cottoni F. Endoscopic examination in Kaposi's sarcoma. J Eur Acad Dermatol Venereol 14 (2000) 225-226
199. Templeton A.C. Studies in Kaposi's sarcoma. Postmortem findings and disease patterns in women. Cancer 30 (1972) 854-867
200. Anthony C.W. Visceral Kaposi's sarcoma. Arch Pathol 70 (1960) 740-746
201. Reed W.B., Kamath M., and Weiss L. Kaposi sarcoma, with emphasis on the internal manifestations. Arch Dermatol 110 (1974) 115-118
202. Krayem A.B., Wali S.O., and Samman Y.S. The diagnostic challenge and management of pulmonary Kaposi's sarcoma in renal transplant recipients. Saudi Med J 22 (2001) 1061-1064
203. Epstein E. Extracutaneous manifestations of Kaposi's sarcoma: a systemic lymphoblastoma. Calif Med 87 (1957) 98-103
204. Bluefarb S.M. Kaposi's sarcoma: multiple idiopatic hemorrhagic sarcoma (1957), Charles C. Thomas, Springfield, IL
205. O'Brien P.H., and Brasfield R.D. Kaposi's sarcoma. Cancer 19 (1966) 1497-1502
206. Acharya S., and Ross J.D. Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count. Int J STD AIDS 18 (2007) 499-500
207. Kahl P., Buettner R., Friedrichs N., Merkelbach-Bruse S., Wenzel J., and Carl Heukamp L. Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature. Pathol Res Pract 203 (2007) 227-231
208. Neff R., Kremer S., Voutsinas L., Waxman M., and Mitty Jr. W. Primary Kaposi's sarcoma of the ileum presenting as massive rectal bleeding. Am J Gastroenterol 82 (1987) 276-277
209. Laine L., Politoske E.J., and Gill P. Protein-losing enteropathy in acquired immunodeficiency syndrome due to intestinal Kaposi's sarcoma. Arch Intern Med 147 (1987) 1174-1175
210. Perrone V., Pergola M., Abate G., Silvestro L., Ronga D., Bruni G., et al. Protein-losing enteropathy in a patient with generalized Kaposi's sarcoma. Cancer 47 (1981) 588-591
211. Biggs B.A., Crowe S.M., Lucas C.R., Ralston M., Thompson I.L., and Hardy K.J. AIDS related Kaposi's sarcoma presenting as ulcerative colitis and complicated by toxic megacolon. Gut 28 (1987) 1302-1306
212. Wang N.C., Chang F.Y., Chou Y.Y., Chiu C.L., Lin C.K., Ni Y.H., et al. Intussusception as the initial manifestation of AIDS associated with primary Kaposi's sarcoma: a case report. J Formos Med Assoc 101 (2002) 585-587
213. Tedesco M., Benevolo M., Frezza F., Mancini R., Carone M.D., Mottolese M., et al. Colorectal Kaposi's sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report. Anticancer Res 19 (1999) 3045-3048
214. Yoshida E.M., Chan N.H., Chan-Yan C., and Baird R.M. Perforation of the jejunum secondary to AIDS-related gastrointestinal Kaposi's sarcoma. Can J Gastroenterol 11 (1997) 38-40
215. Wheeler D.W., and Baigrie R.J. Palliative surgery for acute bowel obstruction caused by Kaposi's sarcoma in a patient with AIDS. Int J Clin Pract 57 (2003) 347-348
216. Hamm P.G., Judson M.A., and Aranda C.P. Diagnosis of pulmonary Kaposi's sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. A report of five cases. Cancer 59 (1987) 807-810
217. Si M.W., Jagirdar J., Zhang Y.J., Gao S.J., and Yeh I.T. Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma. Appl Immunohistochem Mol Morphol 13 (2005) 61-65
218. Lehloenya R., and Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin 24 (2006) 549-570
219. Davis S.D., Henschke C.I., Chamides B.K., and Westcott J.L. Intrathoracic Kaposi sarcoma in AIDS patients: radiographic-pathologic correlation. Radiology 163 (1987) 495-500
220. Angouridakis N., Constantinidis J., Karkavelas G., Vlachtsis K., Mpouras K., and Daniilidis J. Classic (Mediterranean) Kaposi's sarcoma of the true vocal cord: a case report and review of the literature. Eur Arch Otorhinolaryngol 263 (2006) 537-540
221. Shetty R.R. Unusual bone manifestation of Kaposi's sarcoma. Int J STD AIDS 15 (2004) 566-567
222. Caponetti G., Dezube B.J., Restrepo C.S., and Pantanowitz L. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer 109 (2007) 1040-1052
223. Spanu A., Madeddu G., Cottoni F., Manca A., Migaleddu V., Chessa F., et al. Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. Oncology 65 (2003) 295-305
224. Alioua Z., Lamsyah H., Sbai M., Rimani M., Baba N., Ghfir M., and Sedrati O. Pseudo-Kaposi's sarcoma secondary to superficial arteriovenous malformation: Stewart-Bluefarb syndrome. [in French]. Ann Dermatol Venereol 135 (2008) 44-47
225. Kanitakis J., Narvaez D., and Claudy A. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol 134 (1996) 44-46
226. Schwartz R.A. Cutaneous metastatic disease. J Am Acad Dermatol 33 (1995) 161-182
227. Schwartz R.A. Histopathologic aspects of cutaneous metastatic disease. J Am Acad Dermatol 33 (1995) 649-657
228. Lin R.L., and Janniger C.K. Pyogenic granuloma. Cutis 74 (2004) 229-233
229. Allan A.E., Shoji T., Li N., Burlage A., Davis B., and Bhawan J. Two cases of Kaposi's sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8 positive. Am J Dermatopathol 23 (2001) 431-436
230. Schwartz R.A. Stewart-Treves syndrome. In: Demis D.J. (Ed). Clinical Dermatology. 16th ed. (1989), Harper & Row, Inc., Philadelphia 1-6
231. Fernandez G, Schwartz RA. Stewart-Treves syndrome. eMedicine Dermatology [serial online]. March 28, 2007. Available at: http://emedicine.com/derm/topic898.htm. Accessed May 9, 2008.
232. Schwartz R.A., Gallardo M.A., Kapila R., Gascon P., Herscu J., Siegel I., et al. Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. Br J Dermatol 135 (1996) 982-987
233. Schwartz R.A., Nychay S.G., Janniger C.K., and Lambert W.C. Bacillary angiomatosis: presentation of six patients, some with unusual features. Br J Dermatol 136 (1997) 60-65
234. Koehler J.E., Sanchez M.A., Garrido C.S., Whitfeld M.J., Chen F.M., Berger T.G., et al. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 337 (1997) 1876-1883
235. Fayemi A.O., and Toker C. Nodal angiomatosis. Arch Pathol 99 (1975) 170-172
236. Wilken J.J., Meier F.A., and Kornstein M.J. Kaposiform hemangioendothelioma of the thymus. Arch Pathol Lab Med 124 (2000) 1542-1544
237. Schwartz R.A., Dabski C., and Dabska M. The Dabska tumor: a thirty-year retrospect. Dermatology 201 (2000) 1-5
238. Masala M., Montesu M.A., Saccabusi S., and Cottoni F. An immunological study of classic Kaposi's sarcoma. Chronica Dermatol (Roma) 5 (1995) 35-40
239. Edelman D.C., Ketema F., Saville R.D., Herman J., Sill A.M., Gill P.S., et al. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol 16 (2000) 225-237
240. Masini C., Lesnoni La Parola I., Capuano M., Cattani P., Cerimele F., Fadda G., and Cerimele D. Infezione da HHV8 e sarcoma di Kaposi. [in Italian]. G Ital Dermatol Venereol 134 (1999) 315-320
241. Hong A., Davies S., and Lee C.S. Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma. Pathology 35 (2003) 448-450
242. Kazakov D.V., Schmid M., Adams V., Cathomas G., Muller B., Burg G., et al. HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology 206 (2003) 217-221
243. Ryan P., Aarons S., Murray D., Markham T., O'Sullivan S., Lyons F., et al. Human herpesvirus 8 (HHV-8) detected in two patients with Kaposi's sarcoma-like pyogenic granuloma. J Clin Pathol 55 (2002) 619-622
244. Judde J.G., Lacoste V., Briere J., Kassa-Kelembho E., Clyti E., Couppie P., et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 92 (2000) 729-736
245. Katano H., Iwasaki T., Baba N., Terai M., Mori S., Iwamoto A., et al. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 74 (2000) 3478-3485
246. Courville P., Simon F., Le Pessot F., Tallet Y., Debab Y., and Metayer J. Detection of HHV8 latent nuclear antigen by immunohistochemistry. A new tool for differentiating Kaposi's sarcoma from its mimics. Ann Pathol 22 (2002) 267-276
247. Regamey N., Cathomas G., Schwager M., Wernli M., Harr T., and Erb P. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 36 (1998) 1784-1786
248. Engels E.A., Pittaluga S., Whitby D., Rabkin C., Aoki Y., Jaffe E.S., et al. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 16 (2003) 424-429
249. Inoue N., Spira T., Lam L., Corchero J.L., and Luo W. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. J Med Virol 74 (2004) 202-206
250. Cottoni F., Masia I.M., Cossu S., Montesu M.A., Pardini S., and Massarelli G. Classical Kaposi's sarcoma and chronic lymphocytic leukaemia in the same skin biopsy. Report of two cases. Br J Dermatol 139 (1998) 753-754
251. Berg J.W. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J Natl Cancer Inst 38 (1967) 741-752
252. Quaglino P., Durazzo M., and Doveil G.C. Sarcoma di Kaposi disseminato associato a epatite cronica HCV positiva e piasrtinopenia autoimmune in paziente HIV negative. [in Italian]. G Ital Dermatol Venereol 137 (2002) 53-56
253. Quaglino P., Dardano F., and Verrone A. Sarcoma di Kaposi, mollusco contagioso disseminato e leucolachia orale villosa come prime manifestazioni di infezione da HIV. [in Italian]. G Ital Dermatol Venereol 133 (1998) 455-458
254. Liu W., Lacouture M.E., Jiang J., Kraus M., Dickstein J., Soltani K., et al. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol 33 Suppl 2 (2006) 46-51
255. Carbone A. KSHV/HHV-8 associated Kaposi's sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphoma. J Clin Pathol 58 (2005) 626-628
256. Carbone A., Gloghini A., Vaccher E., Cerri M., Gaidano G., Dalla-Favera R., et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 7 (2005) 17-27
257. Ruszczak Z., Mayer-Da Silva A., and Orfanos C.E. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol 9 (1987) 388-398
258. Ruszczak Z., Mayer da Silva A., and Orfanos C.E. Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica 175 (1987) 270-279
259. O'Connell K.M. Kaposi's sarcoma: histopathological study of 159 cases from Malawi. J Clin Pathol 30 (1977) 687-695
260. Satta R., Cossu S., Massarelli G., and Cottoni F. Anaplastic transformation of classic Kaposi's sarcoma: clinicopathological study of five cases. Br J Dermatol 145 (2001) 847-849
261. Pantanowitz L., Dezube B.J., Pinkus G.S., and Tahan S.R. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol 31 (2004) 26-34
262. Marquart K.H. Tubuloreticular structures in Kaposi's sarcoma cells are not an ultrastructural marker for AIDS. Acta Derm Venereol 67 (1987) 367
263. Cerimele D., Carlesimo F., Fadda G., Rotoli M., and Cavalieri S. Anaplastic progression of classic Kaposi's sarcoma. Dermatology 194 (1997) 287-289
264. O'Connell K.M. Kaposi's sarcoma in lymph nodes: histological study of lesions from 16 cases in Malawi. J Clin Pathol 30 (1977) 696-703
265. Celleno L., Tamburro M., Mastroianni A., Cottoni F., and Cerimele D. Aspetti ultrastrutturali del sarcoma di Kaposi. [in Italian]. G Ital Dermatol Venereol 127 (1992) 143-150
266. Hammock L., Reisenauer A., Wang W., Cohen C., Birdsong G., and Folpe A.L. Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients. Mod Pathol 18 (2005) 463-468
267. Pyakurel P., Pak F., Mwakigonja A.R., Kaaya E., Heiden T., and Biberfeld P. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int J Cancer 119 (2006) 1262-1267
268. Uccini S., Sirianni M.C., Vincenzi L., Topino S., Stoppacciaro A., Lesnoni La Parola I., et al. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 150 (1997) 929-938
269. Krown S.E., Metroka C., and Wernz J.C. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7 (1989) 1201-1207
270. Mitsuyasu R.T. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 14 (1987) 13-18
271. Cottoni F., and Montesu M.A. Kaposi's sarcoma classification: a problem not yet defined. Int J Dermatol 35 (1996) 480-483
272. Brambilla L., Boneschi V., Taglioni M., and Ferrucci S. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol 13 (2003) 83-86
273. Nasti G., Talamini R., Antinori A., Martellotta F., Jacchetti G., Chiodo F., et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. J Clin Oncol 21 (2003) 2876-2882
274. Krigel R.L., Laubenstein L.J., and Muggia F.M. Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 67 (1983) 531-534
275. Volberding P.A. Moving towards a uniform staging for human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 7 (1989) 1184-1185
276. Gascón P., and Schwartz R.A. Kaposi's sarcoma. New treatment modalities. Dermatol Clin 18 (2000) 169-175
277. Gascón P., and Schwartz R.A. Treatment of Kaposi's sarcoma. Dermatol Clin 12 (1994) 451-456
278. Masia I., Satta R., Rosella M., Montesu M.A., Masala M.V., and Cottoni F. Terapia del sarcoma di Kaposi classic. [in Italian]. G Ital Dermatol Venereol 135 (2000) 569-578
279. Weintraub C.M., and Skudowitz R.B. Excision of 1,674 classic Kaposi's sarcomas. S Afr J Surg 40 (2002) 80
280. Karrer S., Szeimies R.M., Hohenleutner U., and Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2 (2001) 229-237
281. Abels C., Karrer S., Baumler W., Goetz A.E., Landthaler M., and Szeimies R.M. Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. Br J Cancer 77 (1998) 1021-1024
282. Marchell N., and Alster T.S. Successful treatment of cutaneous Kaposi's sarcoma by the 585-nm pulsed dye laser. Dermatol Surg 23 (1997) 973-975
283. Chun Y.S., Chang S.N., and Park W.H. A case of classical Kaposi's sarcoma of the penis showing a good response to high-energy pulsed carbon dioxide laser therapy. J Dermatol 26 (1999) 240-243
284. Wheeland R.G., Bailin P.L., and Norris M.J. Argon laser photocoagulative therapy of Kaposi's sarcoma: a clinical and histologic evaluation. J Dermatol Surg Oncol 11 (1985) 1180-1185
285. Caccialanza M., Marca S., Piccinno R., and Eulisse G. Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol 22 (2008) 297-302
286. Yildiz F., Genc M., Akyurek S., Cengiz M., Ozyar E., Selek U., and Atahan I.L. Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc 98 (2006) 1136-1139
287. Brambilla L., Labianca R., Fossati S., Ferrucci S., Taglioni M., and Boneschi V. Chemioterapia nel sarcoma di Kaposi mediterraneo (20 anni di esperienza). [in Italian]. G Ital Dermatol Venereol 135 (2000) 433-437
288. Kaplan L., Abrams D., and Volberding P. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 70 (1986) 1121-1122
289. Evans S.R., Krown S.E., Testa M.A., Cooley T.P., and Von Roenn J.H. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol 20 (2002) 3236-3241
290. Di Lorenzo G., Di Trolio R., Montesarchio V., Palmieri G., Nappa P., Delfino M., et al. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer 112 (2008) 1147-1152
291. Aldenhoven M., Barlo N.P., and Sanders C.J. Therapeutic strategies for epidemic Kaposi's sarcoma. Int J STD AIDS 17 (2006) 571-578
292. Potouridou I., Korfitis C., Ioannidou D., Polydorou D., Zakopoulou N., Stratigos A.J., and Katsambas A.D. Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities. Br J Dermatol 158 (2008) 431-432
293. Brambilla L., Romanelli A., Bellinvia M., Ferrucci S., Vinci M., Boneschi V., et al. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. Br J Dermatol 158 (2008) 1339-1344
294. Gill P.S., Tulpule A., Espina B.M., Cabriales S., Bresnahan J., Ilaw M., et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 17 (1999) 1876-1883
295. Tulpule A., Groopman J., Saville M.W., Harrington Jr. W., Friedman-Kien A., Espina B.M., et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 95 (2002) 147-154
296. Bundow D., and Aboulafia D.M. Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma. Am J Clin Oncol 27 (2004) 81-84
297. Krown S.E. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol 22 (2004) 399-402
298. Klein E., Schwartz R.A., Laor Y., Milgrom H., Burgess G.H., and Holtermann O.A. Treatment of Kaposi's sarcoma with vinblastine. Cancer 45 (1980) 427-431
299. Morris A.K., and Valley A.W. Overview of the management of AIDS-related Kaposi's sarcoma. Ann Pharmacother 30 (1996) 1150-1163
300. Turk H.M., Buyukberber S., Camci C., Inaloz H.S., Sari I., Kirtak N., et al. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine. J Dermatol 29 (2002) 657-660
301. Brambilla L., Miedico A., Ferrucci S., Romanelli A., Brambati M., Vinci M., et al. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma. J Eur Acad Dermatol Venereol 20 (2006) 1090-1094
302. Hernandez D.E., and Perez J.R. Advanced epidemic Kaposi's sarcoma: treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine. Int J Dermatol 35 (1996) 831-833
303. Kobayashi K., and Ratain M.J. Pharmacodynamics and long-term toxicity of etoposide. Cancer Chemother Pharmacol 34 Suppl (1994) S64-S68
304. Brambilla L., Labianca R., Boneschi V., Fossati S., Dallavalle G., Finzi A.F., et al. Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer 74 (1994) 2873-2878
305. Gelmann E.P., Longo D., Lane H.C., Fauci A.S., Masur H., Wesley M., et al. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 82 (1987) 456-462
306. Di Trolio R., Di Lorenzo G., Delfino M., and De Placido S. Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review. Int J Immunopathol Pharmacol 19 (2006) 253-263
307. Krown S.E., Northfelt D.W., Osoba D., and Stewart J.S. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol 31 (2004) 36-52
308. Lim S.T., Tupule A., Espina B.M., and Levine A.M. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 103 (2005) 417-421
309. Schwartz R.A. Edmund Klein (1921-1999). J Am Acad Dermatol 44 (2001) 716-718
310. Klein E., Hahn G., Case R.W., Solomon J.A., Schwartz R.A., Boone C.W., et al. Immunotherapy of skin cancer and other neoplasms involving the skin. In: Safai B., and Good R.A. (Eds). Immunodermatology (1981), Plenum Medical Book Co., New York 633-653
311. Little R.F., Wyvill K.M., Pluda J.M., Welles L., Marshall V., Figg W.D., et al. Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol 18 (2000) 2593-2602
312. Krown S.E. Management of Kaposi sarcoma: the role of interferon and thalidomide. Curr Opin Oncol 13 (2001) 374-381
313. Dezube B.J., Krown S.E., Lee J.Y., Bauer K.S., and Aboulafia D.M. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24 (2006) 1389-1394
314. Puri R.K. IL-4 receptor-directed cytotoxin for therapy of AIDS-associated KS tumors. Drug News Perspect 13 (2000) 395-402
315. Hillman J.D., Peng A.T., Gilliam A.C., and Remick S.C. Treatment of Kaposi sarcoma with oral administration of shark cartilage in a human herpesvirus 8-seropositive, human immunodeficiency virus-seronegative homosexual man. Arch Dermatol 137 (2001) 1149-1152
316. Vart R.J., Nikitenko L.L., Lagos D., Trotter M.W., Cannon M., Bourboulia D., et al. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res 67 (2007) 4042-4051
317. Simonart T., Van Vooren J.P., and Meuris S. Treatment of Kaposi's sarcoma with human chorionic gonadotropin. Dermatology 204 (2002) 330-333
318. Bisacchi D., Noonan D.M., Carlone S., Albini A., and Pfeffer U. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries. Biol Chem 383 (2002) 1315-1320
319. Arasteh K., and Hannah A. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma. Oncologist 5 Suppl 1 (2000) 28-31
320. Yarchoan R., Pluda J.M., Wyvill K.M., Aleman K., Rodriguez-Chavez I.R., Tosato G., et al. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity. Crit Rev Immunol 27 (2007) 401-414
321. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., and Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001) 822-832
322. Krown S.E., Li P., Von Roenn J.H., Paredes J., Huang J., and Testa M.A. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 22 (2002) 295-303
323. Bagnato A., and Rosanò L. The endothelin axis in cancer. Int J Biochem Cell Biol 40 (2008) 1443-1451
324. Brenner B., Weissmann-Brenner A., Rakowsky E., Weltfriend S., Fenig E., Friedman-Birnbaum R., et al. Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 95 (2002) 1982-1987
325. Moray G., Basaran O., Yagmurdur M.C., Emiroglu R., Bilgin N., and Haberal M. Immunosuppressive therapy and Kaposi's sarcoma after kidney transplantation. Transplant Proc 36 (2004) 168-170
326. Célestin Schartz N., Chevret S., Paz C., Kerob D., Verola O., Morel P., and Lebbé C. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients. J Am Acad Dermatol 58 (2008) 585-591
327. Babel N., Eibl N., Ulrich C., Bold G., Sefrin A., Hammer M.H., et al. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod. Transpl Infect Dis 10 (2008) 59-62
328. Rosen T. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream. Int J Dermatol 45 (2006) 854-856
329. Kirkwood J. Cancer immunotherapy: the interferon-alpha experience. Semin Oncol 29 (2002) 18-26
330. Butler S.A., and Iles R.K. Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection?. Clin Cancer Res 9 (2003) 4666-4673
331. Paghdal K.V., and Schwartz R.A. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol 57 (2007) 1046-1050
332. Guenova E., Metzler G., Hoetzenecker W., Berneburg M., and Rocken M. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment. Arch Dermatol 144 (2008) 692-693
333. Yilmaz R., Akoglu H., Kirkpantur A., Kilickap S., Arici M., Altun B., et al. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient. Ren Fail 29 (2007) 103-105
334. Boratynska M., Zmonarski S.C., and Klinger M. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus. Int Immunopharmacol 6 (2006) 2018-2022
335. Konstantinopoulos P.A., Sullivan R.J., Karamouzis M.V., and Dezube B.J. Investigational agents for treatment of AIDS-related Kaposi's sarcoma. Expert Opin Investig Drugs 16 (2007) 495-504
336. Campistol J.M., Gutierrez-Dalmau A., and Torregrosa J.V. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 77 (2004) 760-762
337. Zavos G., Bokos J., Papaconstantinou J., Boletis J., Gazouli M., Pappas P., et al. Study of "de novo" malignancies among Greek renal transplant recipients. Transplant Proc 35 (2003) 1399-1403
338. Masood R., Nagpal S., Zheng T., Cai J., Tulpule A., Smith D.L., et al. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood 96 (2000) 3188-3194
339. Bodsworth N.J., Bloch M., Bower M., Donnell D., and Yocum R. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2 (2001) 77-87
340. Aboulafia D.M., Norris D., Henry D., Grossman R.J., Thommes J., Bundow D., et al. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Arch Dermatol 139 (2003) 178-186
341. Cattelan A.M., Trevenzoli M., and Aversa S.M. Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 3 (2002) 451-462
342. Gonzalez de Arriba A., Perez-Gala S., Goiriz-Valdes R., Rios-Buceta L., and Garcia-Diez A. Kaposi's sarcoma treated with topical alitretinoin. Actas Dermosifiliogr 98 (2007) 50-53
343. Bernstein Z.P., Chanan-Khan A., Miller K.C., Northfelt D.W., Lopez-Berestein G., and Gill P.S. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Cancer 95 (2002) 2555-2561
344. Coras B., Hafner C., Reichle A., Hohenleutner U., Szeimies R.M., Landthaler M., et al. Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma. Arch Dermatol 140 (2004) 1504-1507
345. Mocroft A., Youle M., Gazzard B., Morcinek J., Halai R., and Phillips A.N. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 10 (1996) 1101-1105
346. Glesby M.J., Hoover D.R., Weng S., Graham N.M., Phair J.P., Detels R., et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 173 (1996) 1477-1480
347. Mazzi R., Parisi S.G., Sarmati L., Uccella I., Nicastri E., Carolo G., et al. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 15 (2001) 2061-2062
348. Little R.F., Merced-Galindez F., Staskus K., Whitby D., Aoki Y., Humphrey R., et al. A pilot study of cidofovir in patients with Kaposi sarcoma. J Infect Dis 187 (2003) 149-153
349. Noy A., Scadden D.T., Lee J., Dezube B.J., Aboulafia D., Tulpule A., et al. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol 23 (2005) 990-998
350. Leitch H., Trudeau M., and Routy J.P. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy. HIV Clin Trials 4 (2003) 107-114
351. Bower M., Nelson M., Young A.M., Thirlwell C., Newsom-Davis T., Mandalia S., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23 (2005) 5224-5228
352. Murdoch D.M., Venter W.D., Feldman C., and Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22 (2008) 601-610
353. Nasti G., Martellotta F., Berretta M., Mena M., Fasan M., Di Perri G., et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 98 (2003) 2440-2446
354. Hladik W., Dollard S.C., Downing R.G., Kataaha P., Pellett P.E., Karon J.M., et al. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33 (2003) 206-210
355. Newton R., Ziegler J., Bourboulia D., Casabonne D., Beral V., Mbidde E., et al. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. Br J Cancer 89 (2003) 502-504
356. Martro E., Esteve A., Schulz T.F., Sheldon J., Gambus G., Munoz R., et al. Risk factors for human herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 120 (2007) 1129-1135
357. Stebbing J., Portsmouth S., Nelson M., Mandalia S., Kandil H., Alexander N., et al. The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcoma. Int J Cancer 108 (2004) 631-633
358. Marais B.J., Pienaar J., and Gie R.P. Kaposi sarcoma with upper airway obstruction and bilateral chylothoraces. Pediatr Infect Dis J 22 (2003) 926-928
359. Meyer-Rochow G.Y., Lee K.M., Smeeton I.W., and Shaw J.H. Primary Kaposi's sarcoma of the appendix: a rare cause of appendicitis. ANZ J Surg 77 (2007) 402-403
360. Morgan D., Malamba S.S., Orem J., Mayanja B., Okongo M., and Whitworth J.A. Survival by AIDS defining condition in rural Uganda. Sex Transm Infect 76 (2000) 193-197
361. Spano J.P., Salhi Y., Costagliola D., Rozenbaum W., and Girard P.M. Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma. HIV Med 1 (2000) 232-237
362. Nguyen H.Q., Magaret A.S., Kitahata M.M., Van Rompaey S.E., Wald A., and Casper C. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS 22 (2008) 937-945
363. Makombe S.D., Harries A.D., Yu J.K., Hochgesang M., Mhango E., Weigel R., et al. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct 38 (2008) 5-7